Cancer Diagnostic Delay Rates Associated With a Population-Based Screening Trial Evaluating a Cell-Free DNA Multicancer Early Detection Test

Sean Mann, Pedro Nascimento de Lima, Joshua Eagan, Agne Ulyte, Beth Ann Griffin

Open source

DOI
10.1001/jama.2026.6803
Published
2026-07-14
Container
JAMA
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2026.6803,
  title = {Cancer Diagnostic Delay Rates Associated With a Population-Based Screening Trial Evaluating a Cell-Free DNA Multicancer Early Detection Test},
  author = {Sean Mann and Pedro Nascimento de Lima and Joshua Eagan and Agne Ulyte and Beth Ann Griffin},
  year = {2026},
  journal = {JAMA},
  doi = {10.1001/jama.2026.6803},
  url = {https://doi.org/10.1001/jama.2026.6803}
}

RIS

TY  - JOUR
TI  - Cancer Diagnostic Delay Rates Associated With a Population-Based Screening Trial Evaluating a Cell-Free DNA Multicancer Early Detection Test
AU  - Sean Mann
AU  - Pedro Nascimento de Lima
AU  - Joshua Eagan
AU  - Agne Ulyte
AU  - Beth Ann Griffin
PY  - 2026
JO  - JAMA
DO  - 10.1001/jama.2026.6803
UR  - https://doi.org/10.1001/jama.2026.6803
ER  - 

APA

Mann, S., Lima, P. N. D., Eagan, J., Ulyte, A., & Griffin, B. A. (2026). Cancer Diagnostic Delay Rates Associated With a Population-Based Screening Trial Evaluating a Cell-Free DNA Multicancer Early Detection Test. JAMA. https://doi.org/10.1001/jama.2026.6803

Source records